−15.2
Matinas BioPharma Holdings, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−19.2
FY23:
−15.3
FY24:
−15.9
FY25:
−7.01
Change from FY21 to FY25
millions USD
FY21:
16.8
FY22:
4.88
FY23:
13.2
FY24:
9.21
FY25:
0.34
Change from FY21 to FY25
millions USD
FY21:
6.97
FY22:
0.08
FY23:
−0.01
FY24:
9.17
FY25:
3.39
millions USD
FY21:
8.51
FY22:
−14.2
FY23:
−2.04
FY24:
2.50
FY25:
−3.29
(positive)
Change from FY21 to FY23
millions USD
FY21:
−15.5
FY22:
−20.0
FY23:
−15.5
FY24:
–
FY25:
–
All amounts in millions USD